Anti-biofilm Properties of Bacterial Di-Rhamnolipids and Their Semi-Synthetic Amide Derivatives [PDF]
Frontiers in Microbiology, 2017 A new strain, namely Lysinibacillus sp. BV152.1 was isolated from the rhizosphere of ground ivy (Glechoma hederacea L.) producing metabolites with potent ability to inhibit biofilm formation of an important human pathogens Pseudomonas aeruginosa PAO1 ...
Ivana Aleksic +6 more
doaj +13 more sources
High Di-rhamnolipid Production Using Pseudomonas aeruginosa KT1115, Separation of Mono/Di-rhamnolipids, and Evaluation of Their Properties [PDF]
Frontiers in Bioengineering and Biotechnology, 2019 Rhamnolipids (RLs) are important bioproducts that are regarded as promising biosurfactant for applications in oil exploitation, cosmetics, and food industry. In this study, the newly isolated Pseudomonas aeruginosa KT1115 showed high production of di-RLs.
Jie Zhou +11 more
doaj +5 more sources
Production and evaluation of mono- and di-rhamnolipids produced by Pseudomonas aeruginosa VM011 [PDF]
Data in Brief, 2019 Rhamnolipids are amphiphilic compounds secreted by bacteria and possess the emulsification ability. Emulsification ability makes microbial surfactants an excellent candidate for assisting in the breakdown and removal of oil spills. Rhamnolipids have been
Bhagwan Rekadwad +3 more
doaj +4 more sources
Review in Structure–Activity Relationships, Synthetic Regulation, and Applications of Mono/Di-Rhamnolipids [PDF]
MicroorganismsRhamnolipids (RLs) are natural biosurfactants produced by microbial fermentation. They exhibit excellent surface activity, environmental compatibility, and versatile biological activities, with broad application potential in energy development ...
Zhen Li +8 more
doaj +3 more sources
Effect of Mono and Di-rhamnolipids on Biofilms Pre-formed by Bacillus subtilis BBK006. [PDF]
Curr Microbiol, 2016 Different microbial inhibition strategies based on the planktonic bacterial physiology have been known to have limited efficacy on the growth of biofilms communities. This problem can be exacerbated by the emergence of increasingly resistant clinical strains.
De Rienzo MA, Martin PJ.
europepmc +4 more sources
Cytotoxicity of di-rhamnolipids produced by Pseudomonas aeruginosa RA5 against human cancerous cell lines. [PDF]
3 Biotech, 2022 Rhamnolipid biosurfactant produced by Pseudomonas aeruginosa, possesses non-toxicity, environmental compatibility, a wide range of pH (4-8), temperature (4-100 °C), and salinity (1-10%) stability. The application of RLs is worldwide accepted in the pharmaceutical, medicinal, and food industries.
Ankulkar R +4 more
europepmc +3 more sources
High-Yield Di-Rhamnolipid Production by Pseudomonas aeruginosa YM4 and its Potential Application in MEOR [PDF]
Molecules, 2019 Rhamnolipids are a mixture of the homologs species due to variations in the rhamnose units and β-hydroxy fatty acid moieties, mainly including Rha-C10-C10, Rha-Rha-C10-C10, and Rha-C10. In this study, strain P.
Zhuangzhuang Li +4 more
doaj +3 more sources
Synthesis of di-rhamnolipids by the avirulent, mono-rhamnolipid producing strain Pseudomonas aeruginosa ATCC 9027. [PDF]
Biotechnol LettAbstractTo construct a derivative of the avirulent Pseudomonas aeruginosa ATCC 9027 that produces high levels of di-rhamnolipid, that has better physico-chemical characteristics for biotechnological applications than mono-rhamnolipid, which is the sole type produced by ATCC 9027.
González-Valdez A +3 more
europepmc +3 more sources
The post-translational adaptor protein SadB modulates the pathogenicity of Pseudomonas aeruginosa [PDF]
Journal of BacteriologyIn Pseudomonas aeruginosa, SadB acts as a post-translational adaptor protein that binds to the transcriptional regulator AmrZ. Deletion of sadB results in a biofilm-defective, hyperswarming phenotype. To investigate whether SadB contributes to virulence,
Maria Papangeli +5 more
doaj +2 more sources
Molecular Mechanisms Underlying the Pathogenicity of Pseudomonas aeruginosa [PDF]
MedicinaBackground and Objectives: Pseudomonas aeruginosa is a versatile, opportunistic pathogen responsible for a wide spectrum of infections, particularly in immunocompromised patients and those with disrupted epithelial barriers and chronic respiratory ...
Angelika Krūmiņa +4 more
doaj +2 more sources